Cargando…

Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture

CONTEXT: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein that has been widely used as a healing agent for various chronic wounds. It induces the proliferation and metabolism of epithelial cells, regenerates skin cells, and validates skin elasticity. In the previous study, rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sriwidodo, Sriwidodo, Subroto, Toto, Maksum, Iman P., Wathoni, Nasrul, Rostinawati, Tina, Ulya, Himmatul, Putri, Indah U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020833/
https://www.ncbi.nlm.nih.gov/pubmed/32148364
http://dx.doi.org/10.4103/jpbs.JPBS_207_19
_version_ 1783497822801231872
author Sriwidodo, Sriwidodo
Subroto, Toto
Maksum, Iman P.
Wathoni, Nasrul
Rostinawati, Tina
Ulya, Himmatul
Putri, Indah U.
author_facet Sriwidodo, Sriwidodo
Subroto, Toto
Maksum, Iman P.
Wathoni, Nasrul
Rostinawati, Tina
Ulya, Himmatul
Putri, Indah U.
author_sort Sriwidodo, Sriwidodo
collection PubMed
description CONTEXT: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein that has been widely used as a healing agent for various chronic wounds. It induces the proliferation and metabolism of epithelial cells, regenerates skin cells, and validates skin elasticity. In the previous study, recombinant hEGF (rhEGF) had been successfully expressed extracellularly in Escherichia coli (E. coli) BL21 (DE3) using pectate lyase B (PelB) signal peptide. The previous study has shown that the medium concentration and the induction time influenced the production of rhEGF. AIMS: Therefore, this study was conducted to optimize the induction time and medium concentration for rhEGF extracellular secretion then followed by scale-up production. SETTINGS AND DESIGN: This experiment was carried out using E. coli BL21 (DE3) which contains pD881 plasmid that carries hEGF and PelB gene. Optimization design of induction time and medium concentration were obtained using Central Composite Design (CCD). METHODS AND MATERIAL: The method of study started by the rejuvenation of E. coli culture, extracellular secretion, and optimization in the flask scale then followed by scaled-up production with high-cell density culture in the fermenter. STATISTICAL ANALYSIS USED: The optimization was carried out using Response Surface Methodology (RSM) and multi regression analysis. RESULTS: This work showed that the multiplication of 1.5-fold medium concentration with induction time 3h after the culture started gave the best result among another condition in this study. Additionally, the rhEGF production in the fermenter scale was identified by SDS-PAGE Tricine and quantified by ELISA, which showed 122.40 μg of the rhEGF per milliliter medium. CONCLUSIONS: In respect of the result, we conclude that the optimized condition of extracellular secretion was successfully obtained, and gives higher result before the previous study.
format Online
Article
Text
id pubmed-7020833
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-70208332020-03-06 Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture Sriwidodo, Sriwidodo Subroto, Toto Maksum, Iman P. Wathoni, Nasrul Rostinawati, Tina Ulya, Himmatul Putri, Indah U. J Pharm Bioallied Sci Original Article CONTEXT: Human Epidermal Growth Factor (hEGF) is a potential therapeutic protein that has been widely used as a healing agent for various chronic wounds. It induces the proliferation and metabolism of epithelial cells, regenerates skin cells, and validates skin elasticity. In the previous study, recombinant hEGF (rhEGF) had been successfully expressed extracellularly in Escherichia coli (E. coli) BL21 (DE3) using pectate lyase B (PelB) signal peptide. The previous study has shown that the medium concentration and the induction time influenced the production of rhEGF. AIMS: Therefore, this study was conducted to optimize the induction time and medium concentration for rhEGF extracellular secretion then followed by scale-up production. SETTINGS AND DESIGN: This experiment was carried out using E. coli BL21 (DE3) which contains pD881 plasmid that carries hEGF and PelB gene. Optimization design of induction time and medium concentration were obtained using Central Composite Design (CCD). METHODS AND MATERIAL: The method of study started by the rejuvenation of E. coli culture, extracellular secretion, and optimization in the flask scale then followed by scaled-up production with high-cell density culture in the fermenter. STATISTICAL ANALYSIS USED: The optimization was carried out using Response Surface Methodology (RSM) and multi regression analysis. RESULTS: This work showed that the multiplication of 1.5-fold medium concentration with induction time 3h after the culture started gave the best result among another condition in this study. Additionally, the rhEGF production in the fermenter scale was identified by SDS-PAGE Tricine and quantified by ELISA, which showed 122.40 μg of the rhEGF per milliliter medium. CONCLUSIONS: In respect of the result, we conclude that the optimized condition of extracellular secretion was successfully obtained, and gives higher result before the previous study. Wolters Kluwer - Medknow 2019-12 2019-12-30 /pmc/articles/PMC7020833/ /pubmed/32148364 http://dx.doi.org/10.4103/jpbs.JPBS_207_19 Text en Copyright: © 2019 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sriwidodo, Sriwidodo
Subroto, Toto
Maksum, Iman P.
Wathoni, Nasrul
Rostinawati, Tina
Ulya, Himmatul
Putri, Indah U.
Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture
title Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture
title_full Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture
title_fullStr Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture
title_full_unstemmed Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture
title_short Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture
title_sort optimization of secreted recombinant human epidermal growth factor production using pectate lyase b from escherichia coli bl21(de3) by central composite design and its production in high cell density culture
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020833/
https://www.ncbi.nlm.nih.gov/pubmed/32148364
http://dx.doi.org/10.4103/jpbs.JPBS_207_19
work_keys_str_mv AT sriwidodosriwidodo optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture
AT subrotototo optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture
AT maksumimanp optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture
AT wathoninasrul optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture
AT rostinawatitina optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture
AT ulyahimmatul optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture
AT putriindahu optimizationofsecretedrecombinanthumanepidermalgrowthfactorproductionusingpectatelyasebfromescherichiacolibl21de3bycentralcompositedesignanditsproductioninhighcelldensityculture